BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1729770)

  • 1. A cytosolic oxygenase activity involved in the bioactivation of 2-aminofluorene.
    Leist M; Ayrton AD; Ioannides C
    Toxicology; 1992; 71(1-2):7-20. PubMed ID: 1729770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arylamine activation following chronic ethanol ingestion by rats: studies on the liver S9, microsomal and cytosolic fractions and comparison with Aroclor 1254 pretreatment.
    Traynor CA; Shane BS; Hajos AK; Winston GW
    Mutat Res; 1991 Mar; 247(1):153-66. PubMed ID: 2002800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytosolic activation of 2-aminoanthracene: implications in its use as diagnostic mutagen in the Ames test.
    Ayrton AD; Neville S; Ioannides C
    Mutat Res; 1992 Jan; 265(1):1-8. PubMed ID: 1370238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactivation of 6-aminochrysene by animal and human hepatic preparations: contributions of microsomal and cytosolic enzyme systems.
    Marczylo T; Ioannides C
    Mutagenesis; 1994 May; 9(3):233-9. PubMed ID: 7934963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tryptamine on the mutagenic activity of 2-amino-3-methylimidazo(4,5-f) quinoline (IQ) and related azaarenes in the Ames test.
    Abu-Shakra A; Ioannides C; Walker R
    Mutagenesis; 1987 Jan; 2(1):51-6. PubMed ID: 3331694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic activation of 2-amino-3-methylimidazo(4,5-f)quinoline by hepatic preparations--contribution of the cytosolic fraction and its significance to strain differences.
    Abu-Shakra A; Ioannides C; Walker R
    Mutagenesis; 1986 Sep; 1(5):367-70. PubMed ID: 3331675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of 2-aminofluorene mutagenesis in bacteria by inducers of cytochrome P-450d.
    Miller DM; Aust AE; Voorman R; Aust SD
    Carcinogenesis; 1988 Feb; 9(2):327-9. PubMed ID: 3123085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver, kidney and small-intestine microsomal-mediated mutagenicity of carcinogenic aromatic amines.
    Fouarge M; Mercier M; Poncelet F
    Mutat Res; 1984 Jan; 125(1):23-31. PubMed ID: 6361544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The substrate specificity of the rat hepatic cytosolic arylamine oxidase catalyzing the bioactivation of aromatic amines.
    Marczylo T; Ioannides C
    Cancer Lett; 1998 May; 127(1-2):141-6. PubMed ID: 9619870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mutagenicity and interactions of 2- and 4-(acetylamino)fluorene with cytochrome P450 and the aromatic hydrocarbon receptor may explain the difference in their carcinogenic potency.
    Ioannides C; Cheung YL; Wilson J; Lewis DF; Gray TJ
    Chem Res Toxicol; 1993; 6(4):535-41. PubMed ID: 8397005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytosolic potentiation of the rat hepatic microsome mediated mutagenicity of benzidine.
    Smith JN; Ioannides C
    Mutagenesis; 1987 May; 2(3):205-9. PubMed ID: 3325744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The food pyrolysis product IQ enhances its own activation.
    Ayrton AD; Williams EJ; Rodrigues AD; Ioannides C; Walker R
    Mutagenesis; 1989 May; 4(3):205-7. PubMed ID: 2659938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and detoxification of dinitropyrenes by cytosol and microsomes from Aroclor-pretreated rats in the Ames and umu assays.
    Shane BS; Winston GW
    Environ Mol Mutagen; 1997; 30(3):303-11. PubMed ID: 9366909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of the hepatic mixed-function oxidases by Aroclor 1254 in the hamster: comparison of Aroclor-induced rat and hamster preparations in the activation of pre-carcinogens in the Ames test.
    Hyde R; Smith JN; Ioannides C
    Mutagenesis; 1987 Nov; 2(6):477-82. PubMed ID: 3127658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay.
    Prival MJ; Mitchell VD
    Cancer Res; 1981 Nov; 41(11 Pt 1):4361-7. PubMed ID: 7030474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the metabolic bioactivation of n-nitrosopyrrolidine in the rat.
    Cottrell RC; Blowers SD; Walters DG; Lake BG; Purchase R; Phillips JC; Gangolli SD
    Carcinogenesis; 1983; 4(3):311-4. PubMed ID: 6339097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promutagen activation by rodent-liver postmitochondrial fractions in the L5178Y/TK cell mutation assay.
    Amacher DE; Turner GN
    Mutat Res; 1980 Dec; 74(6):485-501. PubMed ID: 7464853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactivation of mushroom hydrazines to mutagenic products by mammalian and fungal enzymes.
    Walton K; Coombs MM; Walker R; Ioannides C
    Mutat Res; 1997 Nov; 381(1):131-9. PubMed ID: 9403039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of aromatic amine mutagenicity in Salmonella typhimurium with rat-liver 9000 g supernatant or monolayers of rat hepatocytes as an activation system.
    Holme JA; Haug LT; Dybing E
    Mutat Res; 1983 Apr; 117(1-2):113-25. PubMed ID: 6339903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dietary fat on hepatic microsomal and cytosolic mutagenic activation of 2-aminofluorene.
    Tsai SY; Pence BC
    Cancer Lett; 1992 Oct; 67(1):87-92. PubMed ID: 1423249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.